Which type of antipsychotic is noted for having a better side effect profile?

Atypical antipsychotics are recognized for having a better side effect profile compared to typical antipsychotics. They are more selective in their action on neurotransmitter receptors, which allows them to manage symptoms of psychosis, such as delusions and hallucinations, effectively while minimizing the risk of certain side effects commonly associated with medications in the typical category, like extrapyramidal symptoms (EPS), which include tremors and rigidity.

Moreover, atypical antipsychotics tend to have a lower risk of tardive dyskinesia, a serious movement disorder that can occur with long-term use of typical antipsychotics. By targeting a broader range of receptors, atypical antipsychotics can also influence mood and may have a more favorable effect on negative symptoms and cognitive function, which are often more challenging to treat.

While all medications carry some risk of side effects, the overall profile of atypical antipsychotics tends to be more tolerable for patients, leading to improved adherence and quality of life. This aspect is particularly important in the context of managing chronic mental health conditions, where long-term treatment is often necessary.